CanSino CEO Xuefeng Yu on Earnings, Pipeline

Xuefeng Yu, Chairman and CEO of CanSino Biologics, discussed the Chinese vaccine company's first-half financial results and clinical pipeline in an interview with Bloomberg. CanSino Biologics develops and manufactures vaccines. The company's pipeline includes candidates in clinical testing phases.

Next story